Director Peter O'Rourke receives 112,859 Quantum Cyber (QUCY) stock options
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Quantum Cyber N.V. director Peter O'Rourke received a grant of stock options described as a "Stock Option (Right to Buy)." The award covers 112,859 options, each exercisable for one ordinary share at an exercise price of $1.45 per share.
The options were granted on July 6, 2026 and are scheduled to expire on July 6, 2036. The filing shows O'Rourke holding a total of 112,859 derivative securities of this type directly following the grant, indicating a compensation-related award rather than an open-market purchase or sale.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
O'Rourke Peter
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 112,859 | $0.00 | -- |
Holdings After Transaction:
Stock Option (Right to Buy) — 112,859 shares (Direct, null)
Footnotes (1)
Key Figures
Options granted: 112,859 options
Exercise price: $1.45 per share
Options held after grant: 112,859 options
+3 more
6 metrics
Options granted
112,859 options
Stock Option (Right to Buy) granted to director on July 6, 2026
Exercise price
$1.45 per share
Conversion or exercise price for each option
Options held after grant
112,859 options
Total derivative securities following the transaction
Grant price per option
$0.00 per option
Award cost at the time of grant
Underlying ordinary shares
112,859 shares
Ordinary shares underlying the stock options
Expiration date
July 6, 2036
Option expiration for the granted stock options
Key Terms
Stock Option (Right to Buy), Grant, award, or other acquisition, Ordinary Shares, derivative securities
4 terms
Stock Option (Right to Buy) financial
"The security is described as a "Stock Option (Right to Buy)" granted to the director."
Grant, award, or other acquisition financial
"The transaction code description is listed as "Grant, award, or other acquisition.""
derivative securities financial
"The filing reports total derivative securities following the transaction of 112,859."
Financial contracts whose value is tied to the price or performance of another asset, such as a stock, bond, commodity, index, or currency; examples include options, futures and swaps. They matter to investors because they let you protect against price swings, bet on future moves or gain larger exposure with less upfront cash—like using a lever or insurance policy on an investment—so they can amplify gains and losses and help manage portfolio risk.
FAQ
What insider transaction did Quantum Cyber N.V. (QUCY) report for Peter O'Rourke?
Quantum Cyber N.V. reported a stock option grant to director Peter O'Rourke. He received 112,859 options to buy ordinary shares as a compensation-related award, rather than through an open-market transaction, according to the Form 4 filing details.
How many Quantum Cyber (QUCY) options were granted to Peter O'Rourke and at what price?
Peter O'Rourke was granted 112,859 stock options, each with an exercise price of $1.45 per share. These options give him the right to buy an equal number of Quantum Cyber ordinary shares at that fixed price in the future.
When do Peter O'Rourke’s Quantum Cyber (QUCY) stock options expire?
Peter O'Rourke’s stock options in Quantum Cyber are scheduled to expire on July 6, 2036. This long-dated expiration provides a multi-year window during which he may choose to exercise the options at the stated $1.45 exercise price.
Is Peter O'Rourke’s Quantum Cyber (QUCY) Form 4 transaction a market buy or sell?
The Form 4 shows an option grant classified as a “Grant, award, or other acquisition,” not a market buy or sell. The options were awarded at a price of $0.00 per option, with a separate $1.45 exercise price for acquiring shares.
What is Peter O'Rourke’s Quantum Cyber (QUCY) derivative position after the option grant?
Following the grant, Peter O'Rourke is reported as holding 112,859 derivative securities of this stock option type. Each option is linked to one underlying ordinary share, aligning his potential future equity exposure with the number of granted options.